Inventor
MCCORD DARLENE E
US10 patents
Patents
10 patentsUS8796315B2Aug 5, 2014
Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
MCCORD DARLENE E11 citations81
US10231939B2Mar 19, 2019
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
MCCORD DARLENE E2 citations71
US9662302B2May 30, 2017
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
MCCORD DARLENE E2 citations71
US9144555B2Sep 29, 2015
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
MCCORD DARLENE E1 citations60
US12478681B2Nov 25, 2025
Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
MCCORD DARLENE E0 citations59
US11638759B2May 2, 2023
Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
MCCORD DARLENE E0 citations59
US9289401B2Mar 22, 2016
Nutritional supplements
MCCORD DARLENE E2 citations59
US9532970B2Jan 3, 2017
Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition
MCCORD DARLENE E1 citations50
US9018237B2Apr 28, 2015
Methods for improved wound closure employing olivamine and endothelial cells
MCCORD DARLENE E0 citations49
US12213993B2Feb 4, 2025
Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereof
MCCORD DARLENE E0 citations39